https://hemogenyx.com/media/hemogenyx-pharmaceuticals-rockefeller-university-collaborating-to-develop-new-lupus-therapies/2019-12-09T07:48:29+00:00https://hemogenyx.com/media/hemogenyx-teams-up-with-global-pharma-company-to-help-further-develop-cdx-antibodies/2020-07-07T18:30:32+01:00https://hemogenyx.com/media/hemogenyx-shares-leap-as-it-signs-collaboration-deal-with-major-us-biotechnology-company/2020-07-07T18:30:54+01:00https://hemogenyx.com/media/hemogenyx-happy-with-progress-and-recent-collaborations/2020-07-07T18:33:10+01:00https://hemogenyx.com/media/mall-cap-share-ideas-pioneering-biotech-firm-hemogenyx-set-to-transform-treatment-of-blood-cancer/2020-07-07T18:34:16+01:00https://hemogenyx.com/media/top-10-biotech-companies-that-are-pushing-the-envelope-in-the-medical-field/2019-12-09T08:04:21+00:00https://hemogenyx.com/media/a-glimpse-at-the-global-blood-disease-market/2019-12-09T08:04:05+00:00https://hemogenyx.com/media/3-breakthrough-cancer-treatments-you-may-not-know-about-but-should/2019-12-09T08:04:29+00:00https://hemogenyx.com/media/hemogenyx-aims-for-revolution-in-blood-cancer-treatment/2020-07-07T18:34:43+01:00https://hemogenyx.com/media/hemogenyx-launching-products-that-could-treat-bone-marrow-transplants-without-chemotherapy/2020-07-07T18:35:43+01:00https://hemogenyx.com/media/biomedical-stock-to-watch-out-for/2019-12-09T08:04:59+00:00https://hemogenyx.com/media/biomedical-stock-to-watch-out-for-2/2019-12-09T08:04:39+00:00https://hemogenyx.com/media/hemogenyx-reverses-into-silver-falcon-issues-shares-to-cornell-uni/2020-07-07T18:35:59+01:00https://hemogenyx.com/media/orgenesis-teams-up-again-with-hemogenyx-to-push-cancer-cell-replacement-to-clinical-trials/2020-07-07T18:30:13+01:00https://hemogenyx.com/media/orgenesis-teams-up-with-hemogenyx-to-develop-its-ahc-platform-in-exciting-deal/2020-07-07T18:29:45+01:00https://hemogenyx.com/media/hemogenyx-ceo-says-progress-definitely-surpassing-expectations/2020-07-07T18:31:09+01:00https://hemogenyx.com/media/hemogenyx-release-successful-cdx-antibody-first-data-results/2020-07-07T18:31:41+01:00https://hemogenyx.com/media/major-honour-for-hemogenyx/2020-07-07T18:32:13+01:00https://hemogenyx.com/media/hemogenyx-are-creating-blood-cancer-treatments-with-us-9-billion-market-potential/2020-07-07T18:32:39+01:00https://hemogenyx.com/media/hemogenyx-pharmaceuticals-to-revolutionise-bone-marrow-transplants/2019-12-09T08:04:24+00:00https://hemogenyx.com/media/hemogenyx-ceo-dr-vladislav-sandler-interviewed-by-zak-mir/2020-07-07T18:36:47+01:00https://hemogenyx.com/media/investival-conference-presentation-november-19-2019/2019-12-09T16:37:20+00:00https://hemogenyx.com/media/the-guardian-mediaplanet-blood-health-q3-2019-page-11-hemogenyx-feature/2020-07-07T18:29:05+01:00https://hemogenyx.com/media/health-awareness-removing-the-toxicity-from-bone-marrow-transplant-conditioning/2019-12-09T16:36:54+00:00https://hemogenyx.com/media/hemogenyx-pharmaceuticals-lon-hemo-up-over-260-as-it-searches-for-covid-antibodies/2020-05-01T23:35:56+01:00https://hemogenyx.com/media/market-talk-with-justin-waite-vadim-alexander-discusses-interim-results-from-hemogenyx-pharmaceuticals/2022-05-04T17:48:56+01:00https://hemogenyx.com/media/total-market-solutions-interview-with-dr-vladislav-sandler-cdx-licence-update/2022-03-24T23:52:42+00:00https://hemogenyx.com/media/the-virus-killer-that-takes-on-the-nuclear-threat-of-infection/2022-03-24T23:52:12+00:00https://hemogenyx.com/media/traders-cafe-with-zak-mir-chimeric-bait-receptor/2022-03-24T23:52:27+00:00https://hemogenyx.com/media/traders-cafe-with-zak-mir-2021-results-and-cbr/2022-05-04T16:09:44+01:00https://hemogenyx.com/media/total-market-solutions-interesting-times-ahead-for-hemogenyx-pharmaceuticals/2022-06-22T13:59:21+01:00https://hemogenyx.com/media/total-market-solutions-interview-with-dr-vladislav-sandler-a-very-bright-future-for-hemogenyx/2023-06-07T20:36:52+01:00https://hemogenyx.com/media/total-market-solutions-positive-news-due-for-for-hemogenyx-pharmaceuticals/2023-06-29T10:41:23+01:00https://hemogenyx.com/media/proactive-investors-hemogenyx-pharmaceuticals-achieves-breakthrough-with-hemo-car-t-program-cbr-platform/2024-03-28T19:57:50+00:00https://hemogenyx.com/media/small-cap-idea-why-investors-should-add-hemogenyx-pharmaceuticals-to-their-watchlist/2024-04-16T12:41:26+01:00https://hemogenyx.com/media/hemogenyx-pharmaceuticals-important-raise-and-car-t-potential-makes-it-one-to-watch/2024-06-27T15:54:40+01:00